Authors: Khan, WN

Citation: Wn. Khan, Regulation of B lymphocyte development and activation by Bruton's tyrosinekinase, IMMUNOL RES, 23(2-3), 2001, pp. 147-156

Authors: Petro, JB Khan, WN

Citation: Jb. Petro et Wn. Khan, Phospholipase C-gamma 2 couples Bruton's tyrosine kinase to the NF-kappa Bsignaling pathway in B lymphocytes, J BIOL CHEM, 276(3), 2001, pp. 1715-1719

Authors: Sleckman, BP Khan, WN Xu, WP Bassing, CH Malynn, BA Copeland, NG Bardon, CG Breit, TM Davidson, L Oltz, EM Jenkins, NA Berman, JE Alt, FW

Citation: Bp. Sleckman et al., Cloning and functional characterization of the early-lymphocyte-specific Pb99 gene, MOL CELL B, 20(12), 2000, pp. 4405-4410

Authors: Petro, JB Rahman, SMJ Ballard, DW Khan, WN

Citation: Jb. Petro et al., Bruton's tyrosine kinase is required for activation of I kappa B kinase and nuclear factor kappa B in response to B cell receptor engagement, J EXP MED, 191(10), 2000, pp. 1745-1753

Authors: Odio, CM Puig, JR Feris, JM Khan, WN Rodriguez, WJ Mccracken, GH Bradley, JS

Citation: Cm. Odio et al., Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children, PEDIAT INF, 18(7), 1999, pp. 581-590